Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. (THRX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
thrx · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Theseus Pharmaceuticals, Inc. (THRX) measures how much investors pay for each dollar of the company's trailing earnings. THRX's current PE ratio of N/A is calculated by dividing its stock price of $4.07 by its TTM earnings per share of -$1.22.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2019 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Theseus Pharmaceuticals, Inc.You THRX | $181M | N/A | — | -$1.22 |
 aTyr Pharma, Inc. ATYR | $43M | N/A | — | -$0.80 |
 CARGO Therapeutics, Inc. Common Stock CRGX | $216M | N/A | — | -$3.72 |
 F-star Therapeutics, Inc. FSTX | $157M | N/A | — | -$1.88 |
 LENZ Therapeutics, Inc. LENZ | $211M | N/A | — | -$2.85 |
 LakeShore Biopharma Co., Ltd LSB | $26M | N/A | — | -$0.94 |
 Selecta Biosciences, Inc. SELB | $135M | N/A | — | -$5.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | — | $-1.22 | — | |
2021-12-31 FY2021 | — | $-0.76 | — | |
2020-12-31 FY2020 | — | $-0.47 | — | |
2019-12-31 FY2019 | — | $-0.28 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Theseus Pharmaceuticals, Inc. (THRX) measures how much investors pay for each dollar of the company's trailing earnings. THRX's current PE ratio of N/A is calculated by dividing its stock price of $4.07 by its TTM earnings per share of -$1.22.
Frequently asked questions
THRX pe ratio · 6 questionsTHRX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.07 and TTM EPS of -$1.22. Data sourced from Financial Modeling Prep via THRX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Theseus Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09